1. Home
  2. IGIC vs VIR Comparison

IGIC vs VIR Comparison

Compare IGIC & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGIC
  • VIR
  • Stock Information
  • Founded
  • IGIC 2001
  • VIR 2016
  • Country
  • IGIC Jordan
  • VIR United States
  • Employees
  • IGIC N/A
  • VIR N/A
  • Industry
  • IGIC Property-Casualty Insurers
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • IGIC Finance
  • VIR Health Care
  • Exchange
  • IGIC Nasdaq
  • VIR Nasdaq
  • Market Cap
  • IGIC 1.0B
  • VIR 859.9M
  • IPO Year
  • IGIC N/A
  • VIR 2019
  • Fundamental
  • Price
  • IGIC $23.49
  • VIR $5.65
  • Analyst Decision
  • IGIC Buy
  • VIR Strong Buy
  • Analyst Count
  • IGIC 2
  • VIR 11
  • Target Price
  • IGIC $31.50
  • VIR $25.73
  • AVG Volume (30 Days)
  • IGIC 100.5K
  • VIR 1.5M
  • Earning Date
  • IGIC 11-04-2025
  • VIR 11-05-2025
  • Dividend Yield
  • IGIC 4.48%
  • VIR N/A
  • EPS Growth
  • IGIC N/A
  • VIR N/A
  • EPS
  • IGIC 2.81
  • VIR N/A
  • Revenue
  • IGIC $525,808,999.00
  • VIR $16,860,000.00
  • Revenue This Year
  • IGIC $6.05
  • VIR N/A
  • Revenue Next Year
  • IGIC $7.01
  • VIR $15.25
  • P/E Ratio
  • IGIC $8.34
  • VIR N/A
  • Revenue Growth
  • IGIC 3.88
  • VIR N/A
  • 52 Week Low
  • IGIC $20.82
  • VIR $4.16
  • 52 Week High
  • IGIC $27.76
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • IGIC 60.52
  • VIR 50.14
  • Support Level
  • IGIC $21.77
  • VIR $4.82
  • Resistance Level
  • IGIC $23.09
  • VIR $5.84
  • Average True Range (ATR)
  • IGIC 0.66
  • VIR 0.37
  • MACD
  • IGIC 0.23
  • VIR -0.03
  • Stochastic Oscillator
  • IGIC 89.93
  • VIR 47.70

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: